{
  "docId": "019de075-3ef2-720b-a168-5d01d166fded",
  "docSlug": "ac5773e53c5b2a016275714deb71033e",
  "documentTitle": "argenx SE | Results Presentation Deck | 16 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 16,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 24,
  "notes": "The table includes hazard ratios, p-values, and mean changes from baseline for CIDP disease progression and functional scores.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3ef2-720b-a168-5d01d166fded/11",
  "deckHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded",
  "deckJsonHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded.json",
  "deckAnchorHref": "/decks/019de075-3ef2-720b-a168-5d01d166fded#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.235,
        "w": 0.307,
        "x": 0.665,
        "y": 0.528
      },
      "kind": "callout",
      "text": "Clinically meaningful measured improvement across efficacy scales. VYVGART Hytrulo patients had mean improvement of 7.7 points on I-RODS and 12.3kPa on mean grip strength in Stage A, which was maintained in Stage B by treated patients and lost in placebo patients.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c284cea7-4701-432e-a68d-0cc13c76a2a1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.08,
        "x": 0.894,
        "y": 0.911
      },
      "kind": "image",
      "text": "argenx logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "08da2014-f2c1-4045-b0cf-0a8f281d9e1f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.798,
        "x": 0.048,
        "y": 0.148
      },
      "kind": "table",
      "text": "Table of secondary endpoints including CIDP progression, functional levels, INCAT scores, I-RODS scores, and grip strength.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c0cfaa39-c18e-4701-ae43-38f47b9a53ca",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.298,
        "x": 0.048,
        "y": 0.075
      },
      "kind": "title",
      "text": "Secondary Endpoints",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "441e051f-4e6b-4b0d-8c5d-fb77afbd9015",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 3,
      "beatId": "9045ec52-5f4b-4381-b557-a87e1704e639",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 3 to 15 present the solution and positive results",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}